<DOC>
	<DOCNO>NCT02004782</DOCNO>
	<brief_summary>Barretts mucosa premalignant condition oesophagus , progress cancer . Oesophageal cancer aggressive , 5 year survival ~15 % . High risk Barretts mucosa , contain high grade dysplasia early cancer , remove endoscopic mucosal resection ( EMR ) gastroscopy . If patient effectively treat EMR premalignant early malignant disease , curative procedure . Currently , major limitation Complete Barretts Excision ( CBE ) EMR , scar tissue development oesophagus , leading stricture formation difficulty swallow ( dysphagia ) . If safe effective method could find reduce risk , treatment option early oesophageal cancer would greatly improve . CBE perform two stage procedure , 2 gastroscopy 8 week apart . In randomised , doubleblind study , eligible enrol patient randomise 1st stage CBE receive either prednisolone tablets placebo . Inclusion criteria patient short segment ( &lt; 3cm circumferential disease ) Barretts oesophagus high grade dysplasia early cancer . The treatment period 6 week CBE session . Prednisolone give reduce dose 6 week , start 40mg daily . The primary outcome symptomatic dysphagia development . Endoscopic dilation perform require dysphagia secondary symptomatic oesophageal stricture formation persist ≥2 day , complete dysphagia time period . Endoscopic surveillance biopsy occur 3 month , 6 month 12 month interval follow CBE , assess complete removal Barretts mucosa . Following two stage CBE , stricture rate without preemptive therapy noncircumferential , circumferential &lt; 2cm , circumferential &lt; 3cm disease , estimate 30 % , 50 % 70 % respectively . The investigator predict 50 % reduction stricture rate oral steroid therapy . With primary analysis oral steroid versus placebo test 5 % level significance two tailed test , 58 patient need per group . Allowing 5 % drop rate , total 126 patient require . The study perform five Australian Tertiary Hospitals , recruitment period estimate 2 year .</brief_summary>
	<brief_title>Barretts oEsophageal Resection With Steroid Therapy Trial</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esophageal Stenosis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . Histologically confirm Barretts mucosa High Grade Dysplasia early adenocarcinoma ( T1a , intramucosal adenocarcinoma ) . 2 . Barretts segment ≥ 30 % circumference , ≤C3 ≤M5 . 3 . The general health condition patient permit anaesthesia endoscopy . 4 . Patient 18 year age old . 5 . Informed consent obtain 1 . Previous ( referral ) biopsies show low grade dysplasia , invasive adenocarcinoma . 2 . Barretts segment &lt; 30 % circumference , &gt; C3 &gt; M5 . 4 . During initial gastroscopy highly suspicious area submucosal invasive cancer ( Kudo pit pattern type V ; excavated/depressed type morphology ; large smooth ulcerated nodule ) . In case significant doubt , initial resection highly suspicious area , urgent histology processing request . If submucosal invasion exclude , patient rebooked 1st stage CBE ( 60 % circumferential resection ) randomization 46 week interval . 4 . Presence tight peptic oesophageal stricture impedes safe effective EMR use Duette cap . 5 . Active malignancy , uncontrolled Diabetes Mellitus , active untreated major psychiatric disorder , uncontrolled infection , uncontrolled hypertension , uncontrolled severe congestive cardiac failure , noncorrectable coagulopathy ( INR &gt; 2 , platelet count &lt; 60 x 109/L ) , osteoporosis , recent peptic ulcer disease , moderatetosevere glaucoma untreated glaucoma , pregnancy . 6 . Unable provide inform consent 7 . Allergy compound use tablet formulation : Microcrystalline cellulose ( MCC ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>